
Bone Therapeutics
Biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
investor investor | €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | €3.3m | Private Placement VC |
Total Funding | 000k |

Nausicaa Ventures(exited)

BAMS Angel Fund(exited)

European Investment Bank(exited)

SFPIM(exited)

Seido Capital(exited)

BioSenic(exited)
EUR | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | 1200 % | 62 % |
EBITDA | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | - | (169 %) | 33 % |
Profit | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (1400 %) | (23 %) | 19 % |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Bone Therapeutics
Edit
ACQUISITION by Bone Therapeutics Aug 2022